News
Michael Osterholm, director of the University of Minnesota's Center for Infectious Disease Research and Policy, said: ...
The FDA also approved treprostinil (Yutrepia) inhalation powder for patients with pulmonary arterial hypertension and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results